Totally (LON:TLY – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at Canaccord Genuity Group in a report issued on Thursday, MarketBeat Ratings reports. They presently have a GBX 20 ($0.26) price objective on the health services provider’s stock. Canaccord Genuity Group’s target price suggests a potential upside of 105.13% from the stock’s current price.
Totally Price Performance
Totally stock opened at GBX 9.75 ($0.13) on Thursday. Totally has a 1-year low of GBX 3.73 ($0.05) and a 1-year high of GBX 11.50 ($0.15). The firm has a market capitalization of £19.16 million, a price-to-earnings ratio of -487.50 and a beta of 0.57. The firm’s fifty day moving average price is GBX 9.08 and its two-hundred day moving average price is GBX 7.16. The company has a current ratio of 0.50, a quick ratio of 0.66 and a debt-to-equity ratio of 14.73.
About Totally
Further Reading
- Five stocks we like better than Totally
- Transportation Stocks Investing
- The Solar Stock Battle: Is Daqo or JinkoSolar Your Next Big Win?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Are These Chinese Stocks a Buy? Michael Burry’s Top Picks Say Yes
- What is the FTSE 100 index?
- Five Below Stock Faces Challenges Despite Strong Revenue Growth
Receive News & Ratings for Totally Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Totally and related companies with MarketBeat.com's FREE daily email newsletter.